These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35468248)

  • 41. In Reply.
    Robb AS;
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):664-666. PubMed ID: 34090655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Authors' reply - anaphylactic shock with methylprednisolone, Kounis syndrome and Hypersitivity to corticosteroids: a clinical paradox.
    Porcaro F; Paglietti MG; Diamanti A; Petreschi F; Schiavino A; Negro V; Pecora V; Fiocchi A; Cutrera R
    Ital J Pediatr; 2019 Jan; 45(1):5. PubMed ID: 30616660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Authors' response to the letter to the editor by Jowsey et al.
    Sanvido O; Schmid K; FitzGerald RE; Roth N; Wilks MF; Bormann P; Hopf NB
    Regul Toxicol Pharmacol; 2019 Apr; 103():330-331. PubMed ID: 30611820
    [No Abstract]   [Full Text] [Related]  

  • 44. Authors' Response to letter by Elkbuli et al.
    Pieracci FM; Leasia K; Bauman Z; Eriksson EA; Lottenberg L; Majercik S; Powell L; Sarani B; Semon G; Thomas B; Zhao F; Dyke C; Doben AR
    J Trauma Acute Care Surg; 2020 Oct; 89(4):e123-e124. PubMed ID: 32618966
    [No Abstract]   [Full Text] [Related]  

  • 45. Authors' reply to the comment by Hanis et al. on "Predictors of unsuccessful pessary fitting in women with prolapse: a cross-sectional study in general practice," by Panman et al.
    Dekker JH; Burger H
    Int Urogynecol J; 2017 Sep; 28(9):1441. PubMed ID: 28748253
    [No Abstract]   [Full Text] [Related]  

  • 46. Authors' response to Finkelstein's letter to the editor regarding our recent review of ambient airborne asbestos concentrations (Abelmann et al., 2015).
    Abelmann A; Glynn ME; Pierce JS; Scott PK; Paustenbach DJ
    Inhal Toxicol; 2016 Nov; 28(13):581-582. PubMed ID: 27706952
    [No Abstract]   [Full Text] [Related]  

  • 47. Authors' reply to the comment by Fusconi et al.
    Dieb W; Moreau N; Hafidi A
    Eur J Pain; 2016 May; 20(5):857-8. PubMed ID: 27059101
    [No Abstract]   [Full Text] [Related]  

  • 48. Authors' reply to the comment by Kendall et al.
    von Dincklage F; Jakuscheit A; Weth J; Lichtner G; Jurth C; Rehberg-Klug B
    Eur J Pain; 2018 Apr; 22(4):823-824. PubMed ID: 29455457
    [No Abstract]   [Full Text] [Related]  

  • 49. Authors' reply to Zhang et al.
    Mantovani A; Bonapace S; Targher G
    Int J Cardiol; 2022 Jun; 356():105. PubMed ID: 35395285
    [No Abstract]   [Full Text] [Related]  

  • 50. Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and Ligibel.
    Martel S; Lambertini M; de Azambuja E
    J Natl Compr Canc Netw; 2022 Jan; 20(1):xlv-xlvi. PubMed ID: 34991073
    [No Abstract]   [Full Text] [Related]  

  • 51. Senior authors' reply to the comment by Andréll et al.
    Gerdle B; Björk M; Dahlström Ö; Vixner L; Äng BO
    Eur J Pain; 2022 Mar; 26(3):766-767. PubMed ID: 34967483
    [No Abstract]   [Full Text] [Related]  

  • 52. Authors' Reply to Davies et al.
    Løhre ET; Klepstad P; Bennett MI; Brunelli C; Caraceni A; Fainsinger RL; Knudsen AK; Mercadante S; Sjøgren P; Kaasa S
    J Pain Symptom Manage; 2016 Nov; 52(5):e1-e2. PubMed ID: 27693897
    [No Abstract]   [Full Text] [Related]  

  • 53. Authors' reply to the comment by Russo et al.
    Pushparaj H; Bhatia A
    Eur J Pain; 2021 Aug; 25(7):1622. PubMed ID: 33961324
    [No Abstract]   [Full Text] [Related]  

  • 54. Authors' reply to the comment by Zhang et al.
    Corp N; Mansell G; Stynes S; Wynne-Jones G; Morsø L; Hill JC; van der Windt DA
    Eur J Pain; 2021 Sep; 25(8):1854. PubMed ID: 34157189
    [No Abstract]   [Full Text] [Related]  

  • 55. Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation".
    Durrani K; Kempen JH; Foster CS;
    Ocul Immunol Inflamm; 2019; 27(1):71. PubMed ID: 29043914
    [No Abstract]   [Full Text] [Related]  

  • 56. Authors' reply to the comment by Shan et al.
    Beilstein CM; Huber M; Engel D; Wuethrich PY
    Eur J Pain; 2023 Apr; 27(4):548-549. PubMed ID: 36762448
    [No Abstract]   [Full Text] [Related]  

  • 57. Authors' reply to Grundtvig Gram et al.
    Hofmann B; Reid L; Rogers WA; Carter SM
    Eur J Epidemiol; 2021 Jun; 36(6):657-658. PubMed ID: 34275017
    [No Abstract]   [Full Text] [Related]  

  • 58. Authors' reply to the comment by Alam et al.
    Kjelgaard Pedersen L; Fisker LYV; Rölfing JD; Ahlburg P; Veien M; Vase L; Møller-Madsen B
    Eur J Pain; 2024 Mar; 28(3):508-509. PubMed ID: 38149765
    [No Abstract]   [Full Text] [Related]  

  • 59. Authors' reply to Zou et al.
    Ciardullo S; Carbone M; Invernizzi P; Perseghin G
    Liver Int; 2023 Nov; 43(11):2579-2580. PubMed ID: 37680048
    [No Abstract]   [Full Text] [Related]  

  • 60. Authors' Response to Letter to the Editor: Adherence in ART: A Comment on Piña et al. (2017).
    Patel VV; Piña C; Dange A; Rawat S; Jadhav U; Chhabra R; Arnsten JH
    J Assoc Nurses AIDS Care; 2018; 29(3):355-356. PubMed ID: 29571684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.